Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Matthews

Showing results (221-230 of 293) with videos related to

Pageof 30
Sort By:
Journal of the International AIDS Society|February 13, 2019
A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015Sofia R Bartlett, Tanya L Applegate, Brendan P Jacka, et al.
Plos One|September 2, 2016
Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual MenDaniel Bradshaw, Jayna Raghwani, Brendan Jacka, et al.
The Medical Journal of Australia|March 3, 2021
Persistent symptoms up to four months after community and hospital-managed SARS-CoV-2 infectionDavid R Darley, Gregory J Dore, Lucette Cysique, et al.
Plos One|November 10, 2011
Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAARTJennifer Audsley, Eric C Seaberg, Joe Sasadeusz, et al.
Hepatology Communications|March 17, 2023
Immediate treatment for recent hepatitis C infection in people with high-risk behaviors: a systematic review and meta-analysisLakshmi Manoharan, Ned H Latham, Stephanie C Munari, et al.
Journal of Viral Hepatitis|March 3, 2020
Transmission of hepatitis C virus in HIV-positive and PrEP-using MSM in EnglandDaniel Bradshaw, Tetyana I Vasylyeva, Chris Davis, et al.
Nature Immunology|January 14, 2022
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infectionChansavath Phetsouphanh, David R Darley, Daniel B Wilson, et al.
AIDS (London, England)|June 27, 2020
Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIVSamira Hosseini-Hooshyar, Marianne Martinello, Jasmine Yee, et al.
Journal of Viral Hepatitis|October 27, 2022
Hepatitis C virus-specific immune responses following direct-acting antivirals administered during recent hepatitis C virus infectionJulia L Casey, Gregory J Dore, Jason Grebely, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 12, 2022
Abnormal left atrial body stiffness is predicted by appendage size: impact of appendage occlusion on left atrial mechanics assessed by pressure-volume analysisAlda Bregasi, James V Freeman, Jeptha P Curtis, et al.
Pageof 30

Showing results (221-230 of 293) with videos related to

Sort By:
Pageof 30
Journal of the International AIDS Society|February 13, 2019
A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015Sofia R Bartlett, Tanya L Applegate, Brendan P Jacka, et al.
Plos One|September 2, 2016
Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual MenDaniel Bradshaw, Jayna Raghwani, Brendan Jacka, et al.
The Medical Journal of Australia|March 3, 2021
Persistent symptoms up to four months after community and hospital-managed SARS-CoV-2 infectionDavid R Darley, Gregory J Dore, Lucette Cysique, et al.
Plos One|November 10, 2011
Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAARTJennifer Audsley, Eric C Seaberg, Joe Sasadeusz, et al.
Hepatology Communications|March 17, 2023
Immediate treatment for recent hepatitis C infection in people with high-risk behaviors: a systematic review and meta-analysisLakshmi Manoharan, Ned H Latham, Stephanie C Munari, et al.
Journal of Viral Hepatitis|March 3, 2020
Transmission of hepatitis C virus in HIV-positive and PrEP-using MSM in EnglandDaniel Bradshaw, Tetyana I Vasylyeva, Chris Davis, et al.
Nature Immunology|January 14, 2022
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infectionChansavath Phetsouphanh, David R Darley, Daniel B Wilson, et al.
AIDS (London, England)|June 27, 2020
Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIVSamira Hosseini-Hooshyar, Marianne Martinello, Jasmine Yee, et al.
Journal of Viral Hepatitis|October 27, 2022
Hepatitis C virus-specific immune responses following direct-acting antivirals administered during recent hepatitis C virus infectionJulia L Casey, Gregory J Dore, Jason Grebely, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 12, 2022
Abnormal left atrial body stiffness is predicted by appendage size: impact of appendage occlusion on left atrial mechanics assessed by pressure-volume analysisAlda Bregasi, James V Freeman, Jeptha P Curtis, et al.
Pageof 30